BACKGROUND: Systems to improve ST-segment-elevation myocardial infarction (STEMI) care have traditionally focused on improving door-toballoon time. However, prompt guideline-directed medical therapy and transradial primary percutaneous coronary intervention (PCI) are also associated with reduced STEMI mortality. The incremental prognostic value of each facet of STEMI care on clinical outcomes within a STEMI system of care is unknown.
D
oor-to-balloon time (D2BT) has been the focus of extraordinary efforts to improve ST-segmentelevation myocardial infarction (STEMI) outcomes, 1,2 and the Center for Medicare and Medicaid Services publically reported hospital D2BT performance in the United States for the past decade. 3 The intense focus on D2BT in STEMI has contributed to dramatic improvements in D2BT performance nationally. [3] [4] [5] [6] As a consequence, Center for Medicare and Medicaid Services has retired the D2BT metric because most American hospitals report perfect or near-perfect D2BT performance among patients presenting directly to percutaneous coronary intervention (PCI)-capable hospitals. 7, 8 Despite D2BT improvements, in-hospital mortality from STEMI in the United States has remained unchanged at ≈5%, 4 highlighting the need for complementary strategies to improve STEMI outcomes. Prompt guideline-directed medical therapy (GDMT) and transradial primary PCI (TR-PPCI) are both associated with improved outcomes in STEMI patients in randomized trials. [9] [10] [11] [12] [13] [14] [15] However, the incremental prognostic value of prompt GDMT before PCI, TR-PPCI, and D2BT is unknown. We investigated the incremental prognostic value of comprehensive STEMI care focusing on prompt GDMT before sheath insertion for PCI, TR-PPCI, and D2BT among consecutive patients with STEMI, including patients transferred from non-PCI-capable facilities.
METHODS

STEMI System of Care
During the study period, we implemented strategies to improve (1) prompt GDMT before sheath insertion for PCI, (2) use of TR-PPCI, and (3) D2BT (Figure 1) . 16 We improved D2BT performance by authorizing emergency department physician catheterization laboratory activation and implementing a policy of immediate patient transfer to an immediately available catheterization laboratory. 17 We standardized the use of prompt GDMT before sheath insertion for PCI using a STEMI Safe Handoff Checklist, which provides clinical decision support for guideline-recommended drugs and dosing in the emergency department. Lastly, we transitioned to a radial first approach for PPCI access rather than an operator-dependent approach. 14, 15, 18 
Study Population
We studied consecutive patients with STEMI treated with PCI at our hospital between January 1, 2011, and December 31, 2016. No patients were excluded. Data were abstracted from the medical record and recorded prospectively by the standards of the National Cardiovascular Data Registry CathPCI Registry. 19 Survival status at 30 days was ascertained retrospectively from the medical record and follow-up phone calls to patients in whom survival status was not available. Survival status at 30 days was complete in 98.7% (n=1255 of 1272) of the study population.
STEMI Care Metrics
We defined prompt GDMT achievement as administration of aspirin, a P2Y12 inhibitor, and unfractionated or low-molecular-weight heparin or bivalirudin before arterial sheath insertion for PCI. TR-PPCI was defined as use of the radial artery for PCI without crossover to femoral access to complete PCI. We defined D2BT achievement by national practice guidelines (≤90 minutes for primary emergency department or in-hospital STEMI and ≤120 minutes for interhospital transfer STEMI).
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Study Outcomes and Statistical Analysis
The outcomes of this study were post-PCI in-hospital adverse events and 30-day mortality. When considering ordinal groups (zero, 1, 2, or 3 metrics achieved), we used Kendall tau-b test of trend for categorical variables and linear regression for continuous variables. We used a log-rank test to assess 30-day all-cause mortality. We performed multivariable logistic regression to assess the risk-adjusted association of STEMI care metric achievement and in-hospital mortality, and we included established clinical predictors of STEMI PCI in-hospital mortality as covariates in the multivariable model. 21 Finally,
WHAT IS KNOWN
• Door-to-balloon time is a well-established metric of ST-segment-elevation myocardial infarction (STEMI) care quality, and national door-to-balloon time performance in the United States has improved drastically during the past 2 decades on the basis of considerable local and national quality improvement initiatives.
• Despite improvements in door-to-balloon time performance in the United States, in-hospital mortality from STEMI has been largely stable on a population level, highlighting the need for complementary strategies to improve STEMI outcomes.
• Prompt administration of guideline-directed medical therapy and use of transradial access for primary percutaneous coronary intervention are each associated with improved outcomes in STEMI patients, but these interventions have not been systematically included in many STEMI quality improvement initiatives.
WHAT THE STUDY ADDS
• In a comprehensive STEMI system focusing on 3 STEMI care metrics ( [1] prompt guideline-directed medical therapy before percutaneous coronary intervention, [2] transradial primary percutaneous coronary intervention, and [3] door-to-balloon time performance), achievement of multiple STEMI care metrics was associated with lower rates of inhospital adverse events and 30-day mortality.
• Expanding STEMI systems of care from a singular focus on door-to-balloon time to a comprehensive focus on multifaceted STEMI care offers an opportunity to improve STEMI outcomes.
we assessed the incremental prognostic value of each STEMI care metric using forward stepwise logistic regression modeling of in-hospital mortality. We included STEMI care metrics in the model in the order each is encountered in clinical practice (first GDMT, second TR-PPCI, third D2BT). For modeling purposes, D2BT was assessed as a continuous variable per 10-minute decrease. We compared the C statistic of the model at each step to assess the incremental improvements. Analyses were performed using SPSS, version 25, Software (IBM Corporation, Armonk, NY). The institutional review board at our hospital approved the study, and no written informed consent from study participants was required. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
RESULTS
Baseline and Procedural Characteristics
Of 1272 cases of STEMI treated with primary PCI, zero STEMI care metrics were achieved in 7.1% (n=90), 1 metric in 24.1% (n=306), 2 metrics in 43.8% (n=557), and 3 metrics were achieved in 25.1% (n=319). Patients with zero metrics were more likely to be women, with in-hospital STEMI presentation, and with higher rates of major comorbidities, including prior congestive heart failure, prior PCI, prior coronary artery bypass grafting, and out-of-hospital cardiac arrest (Table 1) . Intraaortic balloon pumps, mechanical ventilator use, and cardiac arrest in the catheterization laboratory were all more common in patients with zero metrics achieved. Among patients with 1 or 2 metrics achieved, TR-PPCI was the metric least commonly achieved.
In-Hospital Adverse Events and 30-Day Mortality
We observed a graded association between increasing number of metrics achieved and lower rates of bleeding, post-PCI cardiogenic shock, left ventricular ejection fraction ≤35%, cardiovascular mortality, and all-cause mortality ( Table 2) . We observed a similarly graded association between the number of metrics achieved and 30-day all-cause mortality ( Figure 2 ). In-hospital adverse event rates and 30-day mortality in patients with 2 versus 3 metrics achieved were similar (in-hospital mortality, 2.2% versus 2.5%; 30-day mortality, 3.6% versus 3.2%).
Multivariable Adjustment of In-Hospital Mortality
After adjusting for clinical variables known to be associated with STEMI PCI in-hospital mortality, 21 we observed a 61% reduction in the risk-adjusted odds of in-hospital mortality among patients with ≥2 metrics (Table 3) .
Systems-Based Model of STEMI Mortality
In a separate model, each STEMI care metric provided incremental prognostic value in modeling the risk of in-hospital mortality when added sequentially in the order they are delivered clinically (Figure 3 ). When considering administration of GDMT alone (C statistic, 0.601; P<0.001), GDMT+TR-PPCI (C statistic, 0.655; P<0.001), and GDMT+TR-PPCI+D2BT (0.677; P<0.001) in sequence, the C statistic increased with increasing STEMI care metric achievement. Each metric was independently associated with reduced risk of in-hospital mortality in the final model (Table 4) .
DISCUSSION Principal Findings
We observed a graded relationship between increasing number of STEMI care metrics achieved and lower rates of adverse events and 30-day mortality. High-risk patients were those with the fewest metrics achieved and the highest rates of adverse events and mortality. After adjusting for clinical variables known to be associated with STEMI PCI in-hospital mortality, we observed that increasing STEMI care metric achievement remained associated with lower in-hospital mortality. Finally, achievement of each metric provided incremental prognostic value when considered in the order they are delivered clinically. The design of our STEMI system and its relation to STEMI care metrics and clinical outcomes is shown. D2BT indicates door-to-balloon time; ED, emergency department; GDMT, guidelinedirected medical therapy; PCI, percutaneous coronary intervention; STEMI, ST-segmentelevation myocardial infarction; and TR-PPCI, transradial primary percutaneous coronary intervention. CABG indicates coronary artery bypass grafting; D2BT, door-to-balloon time; ED, emergency department; ESRD, end-stage renal disease; GDMT, guideline-directed medical therapy; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; and TR-PPCI, transradial primary percutaneous coronary intervention.
Moving Beyond D2BT
D2BT has been the primary focus of local, regional, and national STEMI quality improvement initiatives. 1, 5, 6 Additionally, Center for Medicare and Medicaid Services public reporting of D2BT performance during the past decade has focused a national spotlight on hospitallevel performance in this important metric. 3 Although American D2BT performance has improved dramatically as a result of these measures, mortality among patients with STEMI has remained relatively unchanged. 3, 4 Further reductions in D2BT performance with goals as low as <60 minutes may be feasible 22 ; however, expanding systems-based strategies to improve STEMI care beyond D2BT may offer novel approaches to reduce STEMI mortality.
Systems Strategies to Promote GDMT
There is major variability in the prompt use of GDMT in patients presenting with STEMI, and strategies to standardize use of prompt GDMT in STEMI are lacking. [23] [24] [25] We have previously shown that use of a STEMI Safe Handoff Checklist improved the rate of GDMT administration before sheath insertion for PCI and was associated with reduced in-hospital mortality. 16 Moreover, the checklist approach to STEMI triage and management, including administration of potent antiplatelet and antithrombotic therapies, appears to be safe without increased risk of bleeding. 16 Systems-based strategies to improve the consistent administration of prompt GDMT in STEMI patients should be encouraged to improve STEMI care and outcomes.
Transradial Primary PCI
TR-PPCI is associated with reduced morbidity and mortality in patients with STEMI in multiple clinical trials. 14, 15, 18 Despite robust evidence supporting its use, TR-PPCI has been slowly adopted in the United States with <25% of STEMI patients receiving TR-PPCI in a contemporary report from the CathPCI registry. 26 Additionally, there is major operator-and hospital-level variability in TR-PPCI adoption in STEMI. Recently TR-PPCI experts have advocated that the D2BT goals in patients treated with TR-PPCI should be prolonged to incentivize TR-PPCI adoption in American STEMI patients. 27 Our findings support that hospitals should strive to standardize the adoption and use of TR-PPCI as the favored approach in STEMI, and operator-level variability should be minimized.
Importance of Multifaceted STEMI Care
STEMI is a highly complex clinical event with multiple competing hazards, including ischemia, arrhythmia, heart failure, bleeding, and vascular injuries. Certain patients may derive benefit from certain aspects of STEMI care in particular. A patient with heavy thrombus burden may respond best to prompt antiplatelet and antithrombotic therapy, whereas a patient with an early presenting anterior wall STEMI may respond best to rapid D2BT. In an elderly woman with delayed presentation and high bleeding risk, TR-PPCI may be the most critical factor. Thus, we believe that the best approach is to consistently achieve a wide range of STEMI care metrics with prompt GDMT, safe TR-PPCI, and rapid reperfusion.
Limitations
First, this is a single-center study that may differ from a national population. However, no patients were excluded from this study which may limit the potential for selection bias, and our population should reflect that of many large referral centers for primary PCI. Second, this is an observational, nonrandomized study. Unmeasured confounding may contribute to the observed results. Third, STEMI system performance may fluctuate over time because of system feedback, operator learning curves, and system refinements. These changes may influence the observed study results. Fourth, this study was not adequately powered to detect possible differences between the achievement of 2 versus 3 STEMI care metrics because of the low event rates in these patients. Lastly, it is well established that clinical factors and other nonsystem variables are important contributors to early mortality in STEMI and should not be dismissed. This is highlighted by our finding that a systems-based model that did not include clinical and nonsystem factors offered less accurate discrimination for in-hospital mortality.
Conclusions
STEMI systems of care have produced remarkable improvements in D2BT in American hospitals in the past decade, but novel strategies to further reduce STEMI morbidity and mortality are needed. System strategies to promote prompt GDMT administration before sheath insertion for PCI and to increase the adoption and consistent use of TR-PPCI in STEMI are associated with improved patient outcomes. Expanding STEMI systems of care from a singular focus on D2BT to a comprehensive focus on multifaceted STEMI care offers an opportunity to further improve STEMI outcomes. 386 . D2BT indicates door-toballoon time; GDMT, guideline-directed medical therapy; OR, odds ratio; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; and TR-PPCI, transradial primary percutaneous coronary intervention. M.A., K.K., V.M., S.H., S.G.E., D.B., S.R.K., U.N.K.), Medicine Institute (J.A.B.), and Emergency Services Institute (T.C.G., S.R.P., S.W.M., D.M.K., E.S.), Cleveland Clinic, OH.
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